BDNF and Alzheimer disease: Moon et al. reported that the administration of AD-MSCs after 3 weeks of spinal cord ischemic injury can exert neuroprotective effects by regulating microglia and brain-derived neurotrophic factor (BDNF) levels in the spinal cord [119].